Concepedia

David Lodge

DL

Statistics

Publications

148

Citations

13.9K

H-Index

61

Active since

1972

Affiliations

Eli Lilly (United States)(Current)

University of Bristol

Royal Veterinary College

Eli Lilly (United Kingdom)

Australian National University

David Lodge is an author at Eli Lilly (United States) specializing in neuropharmacology, neuroscience, and pharmacology.

Publications per year

1972–2018

148

Publications

148

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate

Nabil A. Anis, Stephen C. Berry, N.R. Burton et al. · British Journal of Pharmacology · 1983 · 1.4K citations · Full text

, , +17

Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor Antagonists

Tage Honoré, S.N. Davies, Jørgen Drejer et al. · Science · 1988 · 1.2K citations

, , +17

Evidence for involvement ofN-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the rat

Stephen N. Davies, David Lodge · Brain Research · 1987 · 666 citations

, , +16

An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?

Alex M. Thomson, David C. West, David Lodge · Nature · 1985 · 457 citations

, , +13

A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission

Vernon R. J. Clarke, Barbara A. Ballyk, Ken H. Hoo et al. · Nature · 1997 · 416 citations

, , +14

1–5 of 148